Insufficient scRNA-seq data for expression of SPRY3 at single-cell level.
Insufficient scRNA-seq data for expression of SPRY3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 576.97 | 2641 / 2642 | 85% | 1.96 | 601 / 705 |
adrenal gland | 100% | 511.34 | 258 / 258 | 72% | 1.61 | 166 / 230 |
ovary | 99% | 476.28 | 179 / 180 | 69% | 1.63 | 297 / 430 |
breast | 100% | 422.65 | 459 / 459 | 42% | 0.67 | 464 / 1118 |
kidney | 100% | 271.54 | 89 / 89 | 41% | 0.68 | 367 / 901 |
esophagus | 100% | 269.50 | 1442 / 1445 | 37% | 0.75 | 67 / 183 |
lung | 100% | 362.94 | 577 / 578 | 33% | 0.67 | 386 / 1155 |
stomach | 100% | 210.80 | 358 / 359 | 33% | 0.52 | 95 / 286 |
uterus | 100% | 372.94 | 170 / 170 | 30% | 0.75 | 136 / 459 |
intestine | 100% | 347.01 | 966 / 966 | 25% | 0.38 | 133 / 527 |
bladder | 100% | 305.52 | 21 / 21 | 25% | 0.48 | 127 / 504 |
thymus | 100% | 390.29 | 653 / 653 | 24% | 0.29 | 145 / 605 |
skin | 97% | 198.07 | 1746 / 1809 | 23% | 0.39 | 107 / 472 |
prostate | 100% | 329.26 | 245 / 245 | 12% | 0.18 | 61 / 502 |
pancreas | 94% | 121.69 | 308 / 328 | 15% | 0.21 | 26 / 178 |
liver | 98% | 150.77 | 221 / 226 | 3% | 0.04 | 13 / 406 |
spleen | 100% | 454.15 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 427.81 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 300.63 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 246.54 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 222.25 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 289.46 | 823 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.25 | 8 / 45 |
eye | 0% | 0 | 0 / 0 | 6% | 0.07 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0043407 | Biological process | negative regulation of MAP kinase activity |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0048513 | Biological process | animal organ development |
GO_0150013 | Biological process | negative regulation of neuron projection arborization |
GO_0007399 | Biological process | nervous system development |
GO_0040037 | Biological process | negative regulation of fibroblast growth factor receptor signaling pathway |
GO_0046580 | Biological process | negative regulation of Ras protein signal transduction |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | SPRY3 |
Protein name | Protein sprouty homolog 3 (Spry-3) (Sprouty RTK signaling antagonist 3) (Sprouty3) |
Synonyms | |
Description | FUNCTION: Inhibits neurite branching, arbor length and neurite complexity (By similarity). Inhibits EGF-mediated p42/44 ERK signaling (By similarity). Negatively regulates the MAPK cascade, resulting in a reduction of extracellular matrix protein accumulation . May function as an antagonist of fibroblast growth factor (FGF) pathways and may negatively modulate respiratory organogenesis . . |
Accessions | O43610 ENST00000675360.1 ENST00000302805.7 ENST00000695325.1 |